Phase III Failure Sinks Drug for Rare Neurological Disorder
The Italian biotech Newron is halting the development of the experimental drug sarizotan after it…
The Italian biotech Newron is halting the development of the experimental drug sarizotan after it…
Cambridge University scientists have identified a chemical in the brain that blocks unwanted thoughts, offering a…
Italy may not be the first country that comes to mind when you think of…
UPDATE (12/05/2017): Newron has received €11.3M as a milestone payment for the approval from its…
Philip talked to Stefan Weber, CEO of Newron Pharmaceuticals, in our first meetup in Munich…
We had a look into European biotech and created a map with the biggest biotech…
Biotech is one of the main forces driving the development of effective therapies to treat neurological and…
Newron sees its Investigational New Drug application approved by the FDA. It can now begin…
Italian Pharma Newron and its partner Zambon (from Milan) have been granted a license by Swissmedic…
New success for Newron Pharmaceuticals. The FDA approved Orphan Drug designation to its new chemical…
Newron Pharmaceuticals, a public company focused on novel Central Nervous System (CNS) and pain therapies, announces…